ASX - By Stock
|
SWP |
Re:
Ann: Swoop Beats Free Cash Flow Target in Final Quarter FY23
|
|
Mega96
|
38 |
12K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
POD |
Re:
Ann: Resignation of Managing Director
|
|
Mega96
|
52 |
22K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
52
|
22K
|
1
|
|
ASX - By Stock
|
SWP |
Re:
Ann: Swoop Beats Free Cash Flow Target in Final Quarter FY23
|
|
Mega96
|
38 |
12K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
38
|
12K
|
2
|
|
ASX - By Stock
|
SWP |
Re:
Ann: Swoop Beats Free Cash Flow Target in Final Quarter FY23
|
|
Mega96
|
38 |
12K |
3 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Pax Centre Acquisition to Advance Psychedelic Therapies
|
|
Mega96
|
39 |
9.5K |
6 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
39
|
9.5K
|
6
|
|
ASX - By Stock
|
POD |
Re:
Ann: Key Project Work Gathers Momentum to Inform Feasibility
|
|
Mega96
|
47 |
25K |
3 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
47
|
25K
|
3
|
|
ASX - By Stock
|
IXR Mining |
Re:
General Chat / Discussion
|
|
Mega96
|
8.8K |
3.4M |
1 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
8.8K
|
3.4M
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Strong Recruitment for EMD-RX5 Phase 3 Trial
|
|
Mega96
|
17 |
6.1K |
4 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
17
|
6.1K
|
4
|
|
ASX - By Stock
|
IXR |
Re:
Ann: Makuutu Definitive Feasibility Study
|
|
Mega96
|
106 |
53K |
4 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
106
|
53K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria Grows MDMA Asset for Neuro & Mental Health Therapy
|
|
Mega96
|
6 |
2.3K |
9 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
6
|
2.3K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Entitlement Offer Offer Booklet
|
|
Mega96
|
38 |
11K |
11 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
38
|
11K
|
11
|
|
ASX - By Stock
|
TYR |
Re:
Ann: Tyro Reaches Agreement to Settle Class Action
|
|
Mega96
|
6 |
2.7K |
1 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
6
|
2.7K
|
1
|
|
ASX - By Stock
|
SWP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mega96
|
39 |
24K |
0 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
39
|
24K
|
0
|
|
ASX - By Stock
|
SWP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mega96
|
39 |
24K |
2 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
39
|
24K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Positive clinical data reported at breast cancer symposium
|
|
Mega96
|
110 |
35K |
16 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
110
|
35K
|
16
|
|
ASX - By Stock
|
POD |
Re:
Ann: Update to Board Restructure and Additional AGM Resolution
|
|
Mega96
|
4 |
1.8K |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
ASX - By Stock
|
POD |
Re:
Ann: High Grade Rhodium Identified in Stage 10 5E PGE Assays
|
|
Mega96
|
11 |
3.8K |
2 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
11
|
3.8K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
Mega96
|
317 |
109K |
0 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
317
|
109K
|
0
|
|
ASX - By Stock
|
SWP |
Re:
Swoop’s most recent acquisition - Moose mobile - Thoughts
|
|
Mega96
|
6 |
4.1K |
1 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
6
|
4.1K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Paul Hopper IP opportunists CHM VS RAD
|
|
Mega96
|
28 |
11K |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
28
|
11K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
Mega96
|
51 |
18K |
3 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
51
|
18K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mega96
|
2 |
1.0K |
1 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
MNB |
Re:
Ann: RNT-EP affirms support for Green Hydrogen & Ammonia Project
|
|
Mega96
|
187 |
55K |
6 |
15/05/22 |
15/05/22 |
ASX - By Stock
|
187
|
55K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Mega96
|
31 |
7.7K |
0 |
14/05/22 |
14/05/22 |
ASX - By Stock
|
31
|
7.7K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Mega96
|
31 |
7.7K |
4 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
31
|
7.7K
|
4
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mega96
|
68 |
25K |
0 |
01/05/22 |
01/05/22 |
ASX - By Stock
|
68
|
25K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mega96
|
18 |
7.5K |
6 |
01/05/22 |
01/05/22 |
ASX - By Stock
|
18
|
7.5K
|
6
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Quarterly Results Investor Update Webinar
|
|
Mega96
|
7 |
2.3K |
1 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
7
|
2.3K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
Mega96
|
605 |
225K |
4 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
605
|
225K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Change of Director's Interest Notice MW
|
|
Mega96
|
13 |
2.7K |
4 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
13
|
2.7K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Change of Director's Interest Notice - IT
|
|
Mega96
|
11 |
4.2K |
3 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
11
|
4.2K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Change of Director's Interest Notice - IT
|
|
Mega96
|
11 |
4.2K |
1 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
11
|
4.2K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
$9 Billion Cyber spend in the budget tonight
|
|
Mega96
|
148 |
33K |
2 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
148
|
33K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: $30 million placement to rapidly advance Wolfsberg Lithium
|
|
Mega96
|
329 |
132K |
5 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
329
|
132K
|
5
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Enterprise Sales & TCV Update
|
|
Mega96
|
74 |
26K |
8 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
74
|
26K
|
8
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Enterprise Sales & TCV Update
|
|
Mega96
|
74 |
26K |
19 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
74
|
26K
|
19
|
|
ASX - By Stock
|
RXL |
Re:
Ann: High-Grade Results Ahead of Near Surface Resource Update
|
|
Mega96
|
50 |
27K |
6 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
50
|
27K
|
6
|
|
ASX - By Stock
|
AR9 |
Re:
$9 Billion Cyber spend in the budget tonight
|
|
Mega96
|
148 |
33K |
1 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
148
|
33K
|
1
|
|
ASX - By Stock
|
CTT |
Re:
Pick The Bottom
|
|
Mega96
|
317 |
88K |
1 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
317
|
88K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
Mega96
|
195 |
78K |
30 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
195
|
78K
|
30
|
|
ASX - By Stock
|
VR1 |
Re:
VR1 Chart
|
|
Mega96
|
1.3K |
432K |
7 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
1.3K
|
432K
|
7
|
|
ASX - By Stock
|
TBA |
Re:
Ann: Shamrock Delivers Grades of up to 89.8% Gold
|
|
Mega96
|
57 |
16K |
4 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
57
|
16K
|
4
|
|
ASX - By Stock
|
VR1 |
Re:
VR1 Chart
|
|
Mega96
|
1.3K |
432K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
1.3K
|
432K
|
3
|
|
ASX - By Stock
|
AVA |
Re:
Ann: Investor Presentation
|
|
Mega96
|
82 |
28K |
0 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
82
|
28K
|
0
|
|
ASX - By Stock
|
NXL |
Re:
$1 party
|
|
Mega96
|
7 |
2.4K |
3 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
7
|
2.4K
|
3
|
|
ASX - Day Trading
|
|
Re:
Morning Trading February 17
|
|
Mega96
|
276 |
39K |
1 |
17/02/22 |
17/02/22 |
ASX - Day Trading
|
276
|
39K
|
1
|
|
ASX - By Stock
|
BEZ |
Re:
Ann: Outstanding First Gold Assays from surface at Bau Project
|
|
Mega96
|
23 |
8.2K |
2 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
23
|
8.2K
|
2
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Investor Presentation Briefing Document
|
|
Mega96
|
101 |
30K |
4 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
101
|
30K
|
4
|
|
ASX - By Stock
|
NXL |
Re:
Ann: ASIC investigation update
|
|
Mega96
|
41 |
13K |
1 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
41
|
13K
|
1
|
|
ASX - By Stock
|
CTT |
Re:
Ann: Notice of change of interests of substantial holder
|
|
Mega96
|
20 |
5.4K |
1 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
20
|
5.4K
|
1
|
|